BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24762248)

  • 1. Prevalence of renal dysfunction according to the type of atrial fibrillation and anticoagulation treatment in patients who attended primary care in Spain.
    Barrios V; Escobar C; Calderón A; Zamorano JL
    Future Cardiol; 2014 Mar; 10(2):215-20. PubMed ID: 24762248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of undiagnosed atrial fibrillation and of that not being treated with anticoagulant drugs: the AFABE study.
    Clua-Espuny JL; Lechuga-Duran I; Bosch-Princep R; Roso-Llorach A; Panisello-Tafalla A; Lucas-Noll J; López-Pablo C; Queralt-Tomas L; Giménez-Garcia E; González-Rojas N; Gallofré López M
    Rev Esp Cardiol (Engl Ed); 2013 Jul; 66(7):545-52. PubMed ID: 24776203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CHA
    Beyer-Westendorf J; Kreutz R; Posch F; Ay C
    Int J Cardiol; 2018 Feb; 253():71-77. PubMed ID: 29306476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
    J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke prophylaxis in atrial fibrillation: searching for management improvement opportunities in the emergency department: the HERMES-AF study.
    Coll-Vinent B; Martín A; Malagón F; Suero C; Sánchez J; Varona M; Cancio M; Sánchez S; Montull E; Del Arco C; ;
    Ann Emerg Med; 2015 Jan; 65(1):1-12. PubMed ID: 25182543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
    Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
    Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
    Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
    Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding).
    Roldán V; Marín F; Fernández H; Manzano-Fernández S; Gallego P; Valdés M; Vicente V; Lip GY
    Am J Cardiol; 2013 Apr; 111(8):1159-64. PubMed ID: 23337836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1.
    Friberg L; Skeppholm M; Terént A
    J Am Coll Cardiol; 2015 Jan; 65(3):225-32. PubMed ID: 25614418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
    Banerjee A; Fauchier L; Vourc'h P; Andres CR; Taillandier S; Halimi JM; Lip GY
    J Am Coll Cardiol; 2013 May; 61(20):2079-87. PubMed ID: 23524209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of renal dysfunction in ischaemic stroke and transient ischaemic attack patients with or without atrial fibrillation.
    Laible M; Horstmann S; Rizos T; Rauch G; Zorn M; Veltkamp R
    Eur J Neurol; 2015 Jan; 22(1):64-9, e4-5. PubMed ID: 25091540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of kidney insufficiency in primary care population in Spain: EROCAP study].
    de Francisco AL; De la Cruz JJ; Cases A; de la Figuera M; Egocheaga MI; Górriz JI; Llisterri JI; Marín R; Martínez Castelao A
    Nefrologia; 2007; 27(3):300-12. PubMed ID: 17725449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with atrial fibrillation in a primary care setting: Val-FAAP study.
    Barrios V; Calderón A; Escobar C; de la Figuera M;
    Rev Esp Cardiol (Engl Ed); 2012 Jan; 65(1):47-53. PubMed ID: 22054913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Oliveira MM; Mairesse G; Crijns HJ; Simantirakis E; Atar D; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP
    Europace; 2014 Mar; 16(3):308-19. PubMed ID: 24351881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Care Indicators in Patients With Atrial Fibrillation: Assessment of Sex Differences and Management of Clinical Problems.
    Barón-Esquivias G; Gómez S; Brufau H; García L; Amo C; Gutiérrez JM; Wu L; Salmerón F; Pinilla S; López V
    Rev Esp Cardiol (Engl Ed); 2016 Apr; 69(4):384-91. PubMed ID: 26785689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation in chronic hemodialysis patients: prevalence, types, predictors, and treatment practices in Greece.
    Tsagalis G; Bakirtzi N; Manios E; Chouliaras I; Papagiannidou P; Stamellou E; Akrivos T; Makris F; Psimenou E; Koutroubas G; Xinos K; Vemmos K
    Artif Organs; 2011 Oct; 35(10):916-22. PubMed ID: 21615429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.